Correlation Between EVE Health and Kinatico
Can any of the company-specific risk be diversified away by investing in both EVE Health and Kinatico at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EVE Health and Kinatico into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EVE Health Group and Kinatico, you can compare the effects of market volatilities on EVE Health and Kinatico and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EVE Health with a short position of Kinatico. Check out your portfolio center. Please also check ongoing floating volatility patterns of EVE Health and Kinatico.
Diversification Opportunities for EVE Health and Kinatico
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between EVE and Kinatico is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding EVE Health Group and Kinatico in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kinatico and EVE Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EVE Health Group are associated (or correlated) with Kinatico. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kinatico has no effect on the direction of EVE Health i.e., EVE Health and Kinatico go up and down completely randomly.
Pair Corralation between EVE Health and Kinatico
If you would invest 14.00 in Kinatico on December 22, 2024 and sell it today you would earn a total of 4.00 from holding Kinatico or generate 28.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
EVE Health Group vs. Kinatico
Performance |
Timeline |
EVE Health Group |
Kinatico |
EVE Health and Kinatico Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with EVE Health and Kinatico
The main advantage of trading using opposite EVE Health and Kinatico positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EVE Health position performs unexpectedly, Kinatico can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kinatico will offset losses from the drop in Kinatico's long position.EVE Health vs. Flagship Investments | EVE Health vs. Auctus Alternative Investments | EVE Health vs. Iron Road | EVE Health vs. Australian United Investment |
Kinatico vs. National Storage REIT | Kinatico vs. Alternative Investment Trust | Kinatico vs. Cleanspace Holdings | Kinatico vs. Hudson Investment Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements |